Skip to main content

Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI.

Franzini M, Prontera C, Masotti S, Zucchelli G, Storti S, Passino C, Clerico A

Publication: Clin Chim Acta (2013) • Vol 416 • Page 48-9PMID: 23195029View on PubMed

Purpose

The purpose of this paper was to compare heparinated plasma versus serum cardiac troponin I (cTnI) levels and to compare cTnI measurements between three different platforms.

Conclusion

A very close, linear relationship was found between cTnI levels in serum and heparinated plasma when measured by the Tosoh AIA-2000 platform. Compared to cTnI measurements made by the Beckman Coulter UniCell DxI 800 platform, the Tosoh platform gave significantly lower results (-30.2%), although the two methods were very strongly correlated. cTnI measurements by the Tosoh analyzer were also very strongly correlated with cardiac troponin T (cTnT) measurements by the Roche Cobas analyzer, but the Tosoh measurements were approximately 10-fold higher (y=-1067 + 11.6x).

Studies (1)

Purpose

The purpose of this study was to compare hepariniated plasma versus serum cTnI levels and to compare cTnI measurements between three different platforms using specimens from healthy individuals and patients with cardiac disease, including those with acute myocardial infarction. The authors state that a portion of the plasma was stored at -80 degrees C before analysis, but a direct comparison between frozen and fresh plasma was not performed.

Summary of Findings

A very close, linear relationship was found between cTnI levels in serum and heparinated plasma when measured by the Tosoh AIA-2000 platform (R=0.999). Compared to cTnI measurements made by the Beckman Coulter UniCell DxI 800 platform, the Tosoh platform gave significantly lower results (-30.2%, p=0.0024), although the two methods were very strongly correlated (R=0.991). cTnI measurements by the Tosoh analyzer were also very strongly correlated with cTnT measurements by the Roche Cobas analyzer (R=0.938), but the Tosoh measurements were approximately 10-fold higher (y=-1067 + 11.6x).

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)Frozen
  • Diagnoses

    Normal
    Cardiovascular Disease
  • Platforms

    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Lithium heparin
    None
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Clinical chemistry/auto analyzer SpecificTechnology platform
    Beckman Coulter Uniccell DxI 800
    Roche Cobas e411
    Tosoh AIA-2000